Kala Pharmaceuticals, Inc.
Hedge Funds Holdings
Last updated:
Kala Pharmaceuticals, Inc.‘s stocks are currently a part of 44 hedge funds’ portfolios, which represents 7.86% of the total amount of its stocks outstanding. This makes up a total of 115.84K shares of Kala Pharmaceuticals, Inc.. Compared to the previous quarter, the number fell by -23.36% or -35.30K shares fewer. As for the holding position changes, 15.91% (7) of current hedge fund investors increased the number of shares held, 34.09% (15) of current holders sold a part of the shares held, and 34.09% (15) closed the holdings completely. 4 hedge funds are new holders of Kala Pharmaceuticals, Inc. stock in Q3 2022, it is 9.09% of total holders.
Hedge funds holding Kala Pharmaceuticals (Q4 2017 – Q3 2022)
| Q4 2017 | 64 |
|---|---|
| Q1 2018 | 71 |
| Q2 2018 | 67 |
| Q3 2018 | 69 |
| Q4 2018 | 72 |
| Q1 2019 | 75 |
| Q2 2019 | 67 |
| Q3 2019 | 69 |
| Q4 2019 | 69 |
| Q1 2020 | 95 |
| Q2 2020 | 126 |
| Q3 2020 | 118 |
| Q4 2020 | 119 |
| Q1 2021 | 114 |
| Q2 2021 | 102 |
| Q3 2021 | 102 |
| Q4 2021 | 80 |
| Q1 2022 | 83 |
| Q2 2022 | 60 |
| Q3 2022 | 44 |
Hedge funds changes in Kala Pharmaceuticals positions (Q4 2017 – Q3 2022)
| Q4 2017 | 19 | 22 | 13 | 14 | -4 |
|---|---|---|---|---|---|
| Q1 2018 | 18 | 33 | 11 | 11 | -2 |
| Q2 2018 | 8 | 18 | 24 | 12 | 5 |
| Q3 2018 | 21 | 16 | 14 | 19 | -1 |
| Q4 2018 | 14 | 31 | 12 | 11 | 4 |
| Q1 2019 | 11 | 27 | 19 | 8 | 10 |
| Q2 2019 | 4 | 29 | 16 | 9 | 9 |
| Q3 2019 | 8 | 26 | 16 | 6 | 13 |
| Q4 2019 | 11 | 27 | 15 | 10 | 6 |
| Q1 2020 | 40 | 27 | 16 | 12 | 0 |
| Q2 2020 | 45 | 47 | 21 | 15 | -2 |
| Q3 2020 | 27 | 29 | 35 | 33 | -6 |
| Q4 2020 | 27 | 43 | 30 | 25 | -6 |
| Q1 2021 | 16 | 30 | 36 | 21 | 11 |
| Q2 2021 | 14 | 45 | 19 | 26 | -2 |
| Q3 2021 | 16 | 30 | 28 | 15 | 13 |
| Q4 2021 | 17 | 18 | 33 | 37 | -25 |
| Q1 2022 | 17 | 14 | 36 | 13 | 3 |
| Q2 2022 | 11 | 10 | 24 | 31 | -16 |
| Q3 2022 | 4 | 7 | 15 | 15 | 3 |
Hedge funds changes in Kala Pharmaceuticals stock options (Q4 2017 – Q3 2022)
| Q4 2017 | 0 | 0 |
|---|---|---|
| Q1 2018 | 1,042,000 | 238,000 |
| Q2 2018 | 1,241,000 | 833,000 |
| Q3 2018 | 642,000 | 168,000 |
| Q4 2018 | 510,000 | 55,000 |
| Q1 2019 | 7,000 | 197,000 |
| Q2 2019 | 19,000 | 530,000 |
| Q3 2019 | 395,000 | 147,000 |
| Q4 2019 | 2,249,000 | 200,000 |
| Q1 2020 | 6,505,000 | 14,806,000 |
| Q2 2020 | 3,705,000 | 2,645,000 |
| Q3 2020 | 1,095,000 | 3,356,000 |
| Q4 2020 | 3,287,000 | 3,696,000 |
| Q1 2021 | 2,971,000 | 4,119,000 |
| Q2 2021 | 2,736,000 | 1,758,000 |
| Q3 2021 | 388,000 | 907,000 |
| Q4 2021 | 69,000 | 146,000 |
| Q1 2022 | 79,000 | 172,000 |
| Q2 2022 | 39,000 | 4,000 |
| Q3 2022 | 22,000 | 23,000 |